CLINICAL STUDY OF BABOOL (ACACIA ARABICA WILLD.) AND KUKUNDAR (BLUMEA LACERA D.C.) ON ASRIGDARA by Nidhi Mishra* et al.
AYUSHDHARA             ISSN: 2393-9583 (P)/ 2393-9591 (O) 
 An International Journal of Research in AYUSH and Allied Systems 
AYUSHDHARA | July - August 2019 | Vol 6 | Issue 4  2264 
 
     
 
 
CLINICAL STUDY OF BABOOL (ACACIA ARABICA WILLD.) AND KUKUNDAR (BLUMEA LACERA 
D.C.) ON ASRIGDARA  
Nidhi Mishra1*, Rajesh Chandra Mishra2, Ashwini Kumar Sharma2 
*1MD Scholar, 2Associate Professor, Dept. of Dravyaguna, M.M.M. Govt. Ayurved College, Udaipur, Rajasthan. 
 
KEYWORDS: Asrigdara (DUB), 
Babool Acacia Arabica and 
Kukundar, Blumea Lacera, 
Raktastambhana Chikitisa. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ABSTRACT 
Rakta is known to be a vital substance of body. As the disease is 
characterized by excess flow of blood out of the body, Raktastambhana 
Chikitisa is beneficial. Treatment prescribed for Raktatisara, Raktapitta, 
Raktarsha, Guhyaroga and Garbhasrava is also useful. Considering this 
aspect, Raktastambhaka, Raktsodhana, Raktapittaghna effects are desired 
in treatment. Haemostatic drugs should be used by giving due 
consideration to the association of Doshas diagnosed on the basis of 
colour and smell of the blood. Aims and Objectives: To evaluate the 
efficacy of Babool and Kukundar and comparative clinical study of Babool 
and Kukundar on Asrigdara. Materials and Methods: For the present 
study, patients fulfilling the clinical criteria for diagnosis of Asrigdara will 
be selected irrespective of their age, sex, religion, etc, in random from 
O.P.D. section of M. M. M. Govt. Ayurveda College hospital, Udaipur (Raj.). 
Case history of all the patients was taken in the specially prepared 
proforma. Conclusion: Babool due to its astringent taste and Kunkundar 
due to its bitter taste, both drugs pacify excessive Pitta humour which is 
main cause of Asrigdara. Their chemical constituents possess 
haemostatic and anti-inflammatory properties thus considering these 
facts, these drugs have been selected for present study.  
 
INTRODUCTION 
 Ayurveda is the traditional healing modality 
of the Vedic culture from India. Ayurvedic medicine 
views health as much more than the absence of 
disease. The benefits of Ayurvedic medicine have 
been proven over centuries. Dravyaguna vigyan is 
fundamental, inseparable branch of Ayurveda, 
which deals with study of such Dravyas and its 
properties, actions, dose, time of administration and 
used in various preparations of these drugs. The 
World Health Organization (WHO) estimates that 4 
billion people, 80 percent of the world population, 
presently use herbal medicine for some aspect of 
primary health care. WHO noted that of 119 plant-
derived pharmaceutical medicines, about 74 
percent are used in modern medicine in ways that 
correlated directly with their traditional uses as 
plant medicines by native cultures. Hormonal 
therapy has many side effects in management of 
Asrigdara while these herbal drugs have no side 
effects. Asrigdara is most common gynecological 
disorders. Asrigdara or Dysfunctional uterine 
bleeding (DUB), regular or irregular with 
alterations in amount or duration of menstrual loss, 
commonly implies to excessive regular menstrual 
bleeding or essential menorrhagia. Ayurvedic 
classics defined Rakta Pradara as excessive 
Pradeerana (secretion) of Rajah. The Vayu after 
getting vitiated, increases quantity of Rakta (blood), 
takes Rakta to Rajovaha siras and increases the 
quantity of Rajah that comes out through Rajovaha 
siras and causes Rakta pradara.[1] DUB usually 
occurs either when girls begin to menstruate or 
when women approach menopause, but it can occur 
at any time during a woman's reproductive life. 
About 90% of DUB events happen when ovulation is 
not occurring (Anovulatory DUB). In such cases, 
women do not properly develop and release a 
mature egg. As a result, estrogen is produced 
continuously, causing an overgrowth of the uterus 
lining. The period is delayed in such cases, and 
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when it occurs menstruation can be very heavy and 
prolonged. The other 10% of DUB cases occur in 
women who are ovulating (Ovulatory DUB), but 
progesterone secretion is prolonged because 
estrogen levels are low. This causes irregular 
shedding of the uterine lining and break-through 
bleeding.[2] 
Significance of Study 
1. Mostly female suffered from DUB in reproductive 
age and also during Menopausal age group.  
2. For knowing the effect of Babool and Kukundar 
on Asrigdara.  
3. There are so many side effects by modern 
medicines. So herbal drugs are chosen on DUB.  
4. Babool and Kukundar are haemostatic agent.  
5. Hormonal therapy has many adverse effects on 
body. These herbal drugs are no side effects.  
6. Kukundar has Tikta rasa and Ushna virya. So it 
normalizes the liver function, detoxifying body 
and normalize the hormone level.  
AIMS AND OBJECTIVES 
 To evaluate the efficacy of Babool and Kukundar 
on Asrigdara.  
 For comparative clinical study of Babool and 
Kukundar on Asrigdara.  
MATERIALS AND METHODS 
Selection Criteria of the Patients 
For the present study, patients fulfilling the 
clinical criteria for diagnosis of Asrigdara will be 
selected irrespective of their age, sex, religion, etc. 
in random from O.P.D. section of M.M.M. Govt. 
Ayurveda College hospital, Udaipur (Raj.). Case 
history of all the patients was taken in the specially 
prepared proforma. 
Inclusion Criteria  
Patients fulfilling the following general and 
diagnostic criteria were selected for the present 
study.  
 Patients presenting with symptoms of Asrigdara.  
 Patient having age 14 – 50 yr.  
 Any type of bleeding through vagina.  
Exclusion Criteria  
 Patient suffering from Pelvic pathological 
conditions like as– Tumours, Endometriosis, 
Fibriod, Cysts and Carcinoma.  
 Pregnant female with menorrhagia.  
Investigations Done for the Study  
Routine haematological investigation such 
as Hb%, ESR, BT, CT were carried out before and 
after the treatment. They were also subjected for 
USG wherever required. 
Treatment Groups  
 Group A: In this group, patients were 
administered Babool twak Churna (BT Churna) in 
the dose of 3 gm twice a day for 2 months with 
luke warm water. 
  Group B: In this group, patients were 
administered Kukundar panchang Churna (KP 
Churna) in the dose of 3 gm twice a day for 2 
months with honey. 
 Group C: In this group, patients were 
administered Mixed Churna (BK Churna) in the 
dose of 3 gm twice a day for 2 months with 
honey. 
Criteria of Assessment 
 Most of the symptoms and signs of Asrigdara, 
described in Ayurveda, are subjective in nature 
and to give results objectively and for statistical 
analysis, multi dimensional scoring system was 
adopted. This score was obtained before and 
after the treatment through statistical analysis 
and percentage relief was taken to assess the 
efficacy of treatment. 
 Score was given according to the severity of 
symptoms as– Absence of symptoms= 0, Mild 
degree= 1, Moderate degree= 2 and Severe 
degree= 3.           
 Details of scores adopted of the main sign and 
symptoms in present study were as follows.
Grade Length of cycle                  Quantity of bleeding          Interval of bleeding Painful menses B.T. A.T. 
0  3-5 days 
bleeding 
2 – 3 pads wet per 
day 
24 – 28 days    No complain of pain 
during menses 
  
1 6-7 days 
bleeding 
3 pads wet and 
poured per day 
20 –  24 days Complain of pain during 
menses 
  
2 8-9 days 
bleeding 
4 pads wet and 
poured per day  
15 –  20 days   Take medicine for relief of 
pain during menses 
  
3  >9 days 
bleeding 
> 4 pads wet and 
poured per day  
> 15 days   After taken medicine pain 
during menses persist 
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OBSERVATION AND RESULTS  
In the present study, 10-10 patients were registered in every group but 3 patients could not 
complete the trial. Hence the demographic data is presented according to 30 cases but the clinical data is 
presented according to 27 cases (i.e. 8 in group I, 10 in group II and 9 in group III). 
Effect of the Trial Drug on Profile of Patients 
Table 1: Statistical Analysis of Effect of Therapy in Group I 
S.No. Menstrual 
bleeding 
Mean score % relief 
SD ± SE± ‘t’ P 
BT AT Diff. % 
1. Duration 8.90 5.50 3.40 38.20% 1.93 0.68 4.99 <0.001 
2. Amount 4.00 1.88 2.13 53.13% 1.28 0.45 4.69 <0.001 
3. Interval 1.80 0.88 0.93 51.39% 0.83 0.30 3.14 0.003 
4. Pain 1.80 0.75 1.05 58.33% 0.89 0.31 3.35 0.02 
Table 2: Statistical Analysis of Effect of Therapy in Group II 
S. No. Menstrual 
bleeding 
Mean score Relief 
S.D. ± S.E. ± 
Paired 
‘t’ test 
P 
B.T A.T Diff. % 
1 Duration 11.70 5.80 5.90 50.43% 4.07 1.29 4.59 <0.001 
2 Amount 3.30 1.10 2.20 66.67% 1.40 0.44 4.97 <0.001 
3 Interval 2.30 0.30 2.00 86.96% 1.15 0.37 5.48 <0.001 
4 Pain 2.30 0.40 1.90 82.61% 0.99 0.31 6.04 <0.001 
Table  3: Statistical Analysis of Effect of Therapy in Group III 
S. No. Menstrual 
bleeding 
Mean score Relief 
S.D. ± S.E. ± 
Paired 
‘t’ test 
P 
B.T A.T Diff. % 
1 Duration 8.30 5.22 3.08 37.08% 2.07 0.65 4.71 <0.001 
2 Amount 4.10 2.33 1.77 43.09% 1.59 0.50 3.51 0.02 
3 Interval 1.30 0.56 0.74 57.26% 0.71 0.22 3.33 0.01 
4 Pain 1.80 0.78 1.02 56.79% 1.12 0.35 2.89 0.01 
Table 4: Statistical Analysis of Effect of Therapy in all group 
S.No. Menstrual 
Bleeding 
Gr. I Gr. II Gr. III 
Mean SD Mean SD Mean SD 
1 Duration 3.40 0.12 5.90 0.23 3.08 0.17 
2 Amount 2.13 0.18 2.20 0.37 1.77 0.38 
3 Interval 0.93 0.42 2.00 0.42 0.74 0.35 
4 Pain 1.05 0.50 1.90 0.33 1.02 1.12 
Table 5: Intergroup Comparison over Criteria of Assessment 
S.No. Menstrual 
Bleeding 
Gr. I/ II Gr. I/ III Gr. II/ III ANOVA 
p value T value P value T value P value T value P value 
1 Duration 29.69 <0.001 4.52 <0.001 30.59 <0.001 <0.001 
2 Amount 0.53 0.60 2.54 0.02 2.49 0.02 0.02 
3 Interval 5.37 <0.001 1.01 0.33 7.13 <0.001 <0.001 
4 Pain 4.14 <0.001 0.07 0.94 2.27 0.03 0.02 
Table 6: Overall Effect in Groups in 27 Patients 
Assessment 
Group I Group II Group III Total 
No. % No. % No. % No. % 
Cured 1 11.11% 5 50% 3 33.33% 9 33.33% 
Markedly Improved 2 22.22% 4 40% 3 33.33% 9 33.33% 
Partially Improved 4 44.44% 1 10% 2 22.22% 7 25.93% 
Unchanged 1 11.11% 0 0% 1 11.11% 2 7.41% 
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DISCUSSION 
In the present study the highest percentage 
of patients were found in the age group 31- 50 
years. But sample size is small; hence no definite 
conclusion can be made out. A higher incidence of 
Asrigdara was seen in married woman (73.33%) 
most of them being multiparous (56.67%). Some 
married women had psychological and economical 
stress, sexual activeness and family disturbances 
after marriage also may lead to ‘Asrigdara’. 
Multiparous condition may be a cause of this 
disease because of more surface area of uterus and 
congestion the uterus, which causes excessive 
uterine bleeding due to increased vascularity. The 
more number of patients had Vata pittaj Prakriti 
(53.33%) and Pitta kaphaja Prakriti (23.33%). 
From the present study trial we can conclude Pitta 
Dosha is the main Dosha responsible for Asrigdara 
as more number of patients. The duration of illness 
varied from months to years. Vishamagni symptom 
was seen in maximum chronic patient (70%). 
Maximum number of patients (56.67%) having 
Samyak followed by (43.33%) Asamyak Nidra. 
During menstruation patients had disturbed sleep 
(Asamyak nidra) due to excessive flow of blood P/V 
causing stress to the patients. Majority of the 
women were from middle (36.67%) and lower class 
(23.33%) families and living with hygienic mode of 
life (63.33%). Majority of women were educated 
and their psychological status was found agitated 
(53.33%). Majority of the cases (56.67%) were 
having brisk red bleeding with unclotted blood. 
Some cases (46.67%) had white discharge per 
vaginum, though it was diagnosed occasionally 
during examination. Majority of the cases had mild 
to severe pain (90%) during menstruation. In 
general examination (Pulse, blood pressure, 
temperature, respiratory rate) and systemic 
examination there were no significant pathological 
findings. 
According to observation there was mild 
improvement in anemia. Effect on Haemoglobin was 
due to decrease in excessive blood loss. It had not 
shown significant change on the bleeding time, 
clotting time and ESR. 
Effect of therapies was assessed in the 
patients on the basis of changes observed in the 
features on assessment criteria and statistical 
analysis was done: 
1. Duration of bleeding: Group I has shown 
38.20% relief, while in Group II has 50.43% 
relief and Group III has 37.08%. All are highly 
significant (P < 0.001). 
2. Amount of bleeding: Group I has shown 53.13% 
relief, while in Group II has 66.67% relief and 
Group III has 43.09%. Grp I and II are highly 
significant (P<0.001) while Grp III are significant 
(P = 0.02). 
3. Interval of bleeding: Group I has shown 0.93% 
relief, while in Group II has 86.96% relief and 
Group III has 57.26%. Grp II and III are highly 
significant (P<0.001) while Grp I and III are 
significant (P = 0.003 and P = 0.01). 
4. Menstrual pain: Group I has shown 1.05% 
relief, while in Group II has 0.93% relief and 
Group III has 56.79%. All are significant (P = 
0.02, P = 0.003 and P = 0.01). 
The fundamentals of Ayurvedic pharmacology 
are capable to give a better scientific lead in mode 
of the drug action. Pharmacology of Ayurveda is 
based on the theory of Rasa, Guna, Virya, Vipaka and 
Prabhava which were the simplest parameters in 
those days to ascertain the action of the drug. 
Samprapti vighatana is said to be the treatment. 
Therefore, the action of a drug means to dismantle 
the Samprapti Ghatakas of the disease. Hence to 
explain the mode of action of a drug means to 
establish a relationship between the Samprapti 
Ghatakas of the disease and pent fold principles of 
Rasa, Guna, Veerya, Vipaka and Prabhava of a drug. 
Acharya Charaka explains drug action as- 
Certain drugs act through Rasa; some through 
Veerya, some through their Gunas, some through 
their Vipaka and some through their Prabhava.[3] In 
this clinical study we are studying the result of drug 
Babool and Kukundar on Asrigdara. Based on these 
results and Charakas general principle the probable 
mode of action of Babool and Kukundar in the 
disease Asrigdara is being discussed here: 
Mode of action of Babool in Asrigdara 
Babool possesses Kashaya rasa and Sheet 
Veerya.[4] Tannic acid which is main chemical 
constituent of Babool, is astringent as well as 
haemostatic in nature. Predominance of Kashaya 
rasa results in constriction of micro channels and 
vessels. Thus stop bleeding and reduce swelling.  
As per modern concept, the derangement of 
blood is mainly related to its clotting or bleeding 
values. Increase in bleeding time is mainly related 
to the Ushna guna of Pitta. Its astringent taste and 
cooling property soothes the irritable nature of 
excess Pitta in the blood thus reduces inflammation. 
Probable role of this compound is vasoconstriction 
and haemostatic action. This may be due to Phenol 
hydroxyl groups of Tannins which are capable of 
reacting strong hydrogen bonds with atoms of the 
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peptide binding protein thus inhibiting thrombin 
for example, a proteolysis enzyme that converts 
fibrinogen a soluble molecule in a molecule 
insoluble fibrin.  
Mode of action of Kukundar in Asrigdara 
Acharya Charaka primarily indicated the 
use of Tikta rasa for Agni deepana, Rakta skandana 
karma and more specifically for Dosha pachana.[5] 
The treatment principle of Asrigdara is Ama harana 
of Pitta, Tikta rasa considered best to pacify 
excessive Aama. Thus Herbs having bitter taste eg 
(Kukundara) are usually indicated in Asrigdara.[6] 
Despite that Tikta rasa also ignite the fire (Agni 
deepana karma) (primarily Dhatwagni) thus 
ultimately resulted in Rakta Skandana by these two 
phenomenon.  
Active constituents of Blumea lacera are 
Isoflavonoids such as Ferinone, Comferyl, 
hentriacontane, hentriacontanol promotes capillary 
spasm (Vasoconstriction) and prompt clot 
formation resulting in ceasation of bleeding. In 
addition anti-inflammatory action also promotes 
resolution of inflammation.[7] 
Vitamin C component of Blumea lacera 
regulate blood clotting mechanism by maintaining 
of prothrombin, thrombin and thrombokinase 
concentrations, thus reduced the clotting time upto 
normal range. 
It is important to emphasize here that 
addition of mineral elements as Ca, Fe, S, K, P, Mg, 
Mn. Ca is required for the activation of factors like 2, 
7, 9, 10. Ca required cofactors for prothrombin 
activation enzyme complexes to functions. Ca 
converts prothrombin to thrombin. Calcium 
mediates the binding of tenase enzyme complexes 
to the phospholipid surfaces expressed by platelets, 
which in turn activates prothrombin to produce 
thrombin which produces fibrin to fibrinogen. 
Despite Ca, other minerals (Fe, S, K, P, Mg, Mn) plays 
an important role in blood coagulation. 
CONCLUSION 
Rakt Pradar/Asrigdara is a disease of 
menstrual cycle which is characterized by excessive 
and/or prolonged bleeding per vaginum during 
menses or even in between the menses and 
different from the feature of normal menstrual 
blood. Asrigdara is a disease caused by vitiation of 
all the three Doshas, with a clear predominance of 
Pitta. Asrigdara has very close resemblance with 
Dysfunctional uterine bleeding (DUB) for which no 
organic or pelvic pathology can be found out, 
Etiology of the disease is mainly hormonal. The 
main principle of the management of Asrigdara is 
same as Raktapitta as Raktastambhana, Rakta-
sodhana and Vatanulomana.[8] Dipaniya and 
Pachaniya drugs are essential in the treatment of 
Asrigdara for proper Agni and which helps in 
proper metabolism. Babool due to its astringent 
taste and Kunkundar due to its bitter taste, both 
drugs pacify excessive Pitta humour which is main 
cause of Asrigdara. Their chemical constituents 
possess haemostatic and anti-inflammatory 
properties thus considering these facts this drugs 
have been selected for present study.  
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